T. Rowe Price Investment Management, Inc. - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 82 filers reported holding UTAH MED PRODS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$28,321
-10.9%
329,312
-3.5%
0.02%
-9.1%
Q2 2023$31,793
-4.1%
341,118
-2.5%
0.02%
-8.3%
Q1 2023$33,155
-3.5%
349,840
+2.3%
0.02%
-7.7%
Q4 2022$34,373
-99.9%
341,916
-0.1%
0.03%
+13.0%
Q3 2022$29,192,000342,1870.02%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 40,000$4,000,0005.64%
Clean Yield Group 14,474$1,447,0000.46%
RICE HALL JAMES & ASSOCIATES, LLC 113,833$11,383,0000.40%
Ranger Investment Management 68,730$6,873,0000.38%
ISTHMUS PARTNERS, LLC 17,534$1,753,0000.29%
Cardinal Capital Management 10,097$1,010,0000.20%
GLOBEFLEX CAPITAL L P 19,420$1,942,0000.20%
Ancora Advisors LLC 26,689$2,669,0000.06%
Penobscot Investment Management Company, Inc. 4,000$400,0000.05%
SEIZERT CAPITAL PARTNERS, LLC 10,430$1,043,0000.05%
View complete list of UTAH MED PRODS INC shareholders